Edition:
United Kingdom

Aurinia Pharmaceuticals Inc (AUP.TO)

AUP.TO on Toronto Stock Exchange

8.83CAD
23 May 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$8.83
Open
$8.72
Day's High
$9.08
Day's Low
$8.72
Volume
78,714
Avg. Vol
67,209
52-wk High
$10.47
52-wk Low
$6.61

About

Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Company's primary business is the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis (LN). It is focused on the development of its lead... (more)

Overall

Beta: 1.56
Market Cap(Mil.): $800.59
Shares Outstanding(Mil.): 91.65
Dividend: --
Yield (%): --

Financials

  AUP.TO Industry Sector
P/E (TTM): -- 95.23 35.62
EPS (TTM): -1.02 -- --
ROI: -40.04 7.52 11.69
ROE: -46.08 8.09 16.40

Earnings vs. Estimates